Skip to main content

Table 1 Primary antibodies used for immunohistochemistry in the current study.

From: Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry

Antibody (anti-) Clone Manufacturer Working concentration
Oestrogen Receptor polyclonal   Zymed (South San Francisco, Ca) 1:50
Progesterone Receptor monoclonal PR 4-12 EMD Biosciences (San Diego, Ca) 1:10
ERB-B2 polyclonal   Dako (Glostrup, Denmark) 1:50
Cytokeratin 14 monoclonal Ab-1 (LL002) NeoMarkers (Fremont, Ca) 1:300
Cytokeratins 5/6 monoclonal D5/16B4 Zymed (South San Francisco, Ca) 1:100